header image

Production Plants

Using the latest technology and a strict Quality Control process, Octapharma’s production plants carry out plasma fractionation and purification, pharmaceutical production, R&D, and/or product labelling, packaging, storage, and distribution.


First Octapharma's state-of-the-art manufacturing site, acquired from Schwab in Vienna, Austria in 1990.

Located near Strasbourg, France, the facility was acquired in April 1999 from Aventis to increase capacity   




Acquire third manufacturing site from Biovitrum in Stockholm, Sweden, to increase product portfolio


Following successful cooperation with the German Red Cross, Octapharma leased their Plasma Fractionation Facility in 2006 and acquired the facility in 2008.

A modern, state-of-the-art packaging and logistics centre for worldwide distribution, since 2009 our plasma products are labelled, packed, stored and distributed from this centre to more than 113 countries. 

In 1999, five years after Octapharma entered the Mexican market, the board decided to invest in a local manufacturing site. Today Octapharma S.A de C.V is the only producer of blood derivatives in Mexico.